ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,931.57
      1.66%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vivos Therapeutics Inc (VVOS)

      7. Vivos Therapeutics Inc (VVOS) News

      VVOS

      Vivos Therapeutics (VVOS)

      Vivos Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VVOS
      DateTimeSourceHeadlineSymbolCompany
      04/09/20247:30AMGlobeNewswire Inc.Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementNASDAQ:VVOSVivos Therapeutics Inc
      03/28/20244:05PMGlobeNewswire Inc.Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
      03/28/20247:30AMGlobeNewswire Inc.Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
      02/15/20248:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
      02/15/20248:00AMGlobeNewswire Inc.Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross ProceedsNASDAQ:VVOSVivos Therapeutics Inc
      02/14/20245:42PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
      02/06/20247:30AMGlobeNewswire Inc.Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth OpportunitiesNASDAQ:VVOSVivos Therapeutics Inc
      01/08/20247:30AMGlobeNewswire Inc.Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSANASDAQ:VVOSVivos Therapeutics Inc
      12/11/20237:30AMGlobeNewswire Inc.Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”NASDAQ:VVOSVivos Therapeutics Inc
      12/04/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VVOSVivos Therapeutics Inc
      12/01/20234:12PMEdgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:VVOSVivos Therapeutics Inc
      11/30/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
      11/30/20234:03PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
      11/29/20237:30AMGlobeNewswire Inc.Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep ApneaNASDAQ:VVOSVivos Therapeutics Inc
      11/22/20234:46PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VVOSVivos Therapeutics Inc
      11/14/20234:05PMGlobeNewswire Inc.Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
      11/09/20234:30PMGlobeNewswire Inc.Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
      11/03/20235:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VVOSVivos Therapeutics Inc
      11/02/20235:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
      11/02/20235:00PMGlobeNewswire Inc.Vivos Therapeutics Closes $4 Million Private PlacementNASDAQ:VVOSVivos Therapeutics Inc
      10/31/20238:00AMGlobeNewswire Inc.Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VVOSVivos Therapeutics Inc
      10/27/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
      10/26/20237:30AMGlobeNewswire Inc.Vivos Therapeutics Announces Reverse Stock SplitNASDAQ:VVOSVivos Therapeutics Inc
      10/24/20237:30AMGlobeNewswire Inc.Vivos Therapeutics Signs Nationwide Distribution Agreement with LincareNASDAQ:VVOSVivos Therapeutics Inc
      10/11/20237:30AMGlobeNewswire Inc.Vivos Therapeutics to Begin Clinical Trial at Stanford MedicineNASDAQ:VVOSVivos Therapeutics Inc
      10/05/20237:30AMGlobeNewswire Inc.Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International ExpansionNASDAQ:VVOSVivos Therapeutics Inc
      10/04/20233:55PMAllPennyStocks.comBiotech Soars On New AgreementsNASDAQ:VVOSVivos Therapeutics Inc
      10/04/20237:30AMGlobeNewswire Inc.Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of ProvidersNASDAQ:VVOSVivos Therapeutics Inc
      10/02/20237:30AMGlobeNewswire Inc.New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness ConferenceNASDAQ:VVOSVivos Therapeutics Inc
      09/25/20239:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:VVOS